Company intelligence / Profile preview

Nidor Diagnostics

Liverpool, Merseyside, United Kingdom

Ownership: Private
Development stage: Other

Overview

Developing gas-based diagnostic tests from stool samples to positively diagnose IBS and distinguish it from healthy bowels or inflamed bowels; validation ongoing with partner lab as of 2021 plans for late 2021 launch

Therapeutic areas: Gastroenterology
Modalities: Diagnostic test
Industry: Metabolite Diagnostics

Partnerships

Accredited clinical laboratory (unnamed)

Beyond the preview

Go deeper on Nidor Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nidor Diagnostics.

Explore the full profile